For years Republicans and Democrats alike have touted the medical breakthroughs at Texas medical research institutions like ...

Two doctors fell in love while researching different types of rare cancers at MD Anderson Cancer Center. They were coworkers ...

Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

Melvyn N. Klein – known widely for his civic involvement, philanthropy and business acumen – passed away after a long battle ...

Houston-based MD Anderson Cancer Center has named Artemio Mier associate vice president of revenue cycle, patient business services, according to a Feb. 2 post on his LinkedIn page. Mr. Mier has ...

Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer ...

HOUSTON and SALT LAKE CITY, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to ...

“That’s quite an accomplishment,” says Allison, professor and chair of immunology at The University of Texas MD Anderson Cancer Center. Ipilimumab received FDA approval for use in late-stage ...

The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education and prevention. MD Anderson provides ...

A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and ...